Target intelligence / Profile preview

RN7SK pseudogene 292 (RN7SKP292)

Target: RN7SKP292
Molecular classification: Other (Pseudogene; neither receptor, enzyme, transporter, channel, transcription factor, nor histone-modifier)

Overview

RN7SK pseudogene 292 (RN7SKP292) is classified as a pseudogene—an inactive genomic sequence resulting from the duplication of the functional 7SK small nuclear RNA gene (RN7SK). Unlike the original RN7SK, which encodes a non-coding RNA involved in transcriptional regulation, RN7SKP292 is not transcribed into a functional product and does not play a role in molecular signaling or cellular processes. Pseudogenes such as RN7SKP292 generally do not exhibit biological activity and do not represent druggable or therapeutic targets in clinical pharmacology.

Other names: RN7SKP292RNA, 7SK small nuclear pseudogene 292

Beyond the preview

Go deeper on RN7SK pseudogene 292 (RN7SKP292).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RN7SK pseudogene 292 (RN7SKP292).

Explore the full profile